IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: A few years later, the efficacy of human leucocyte IFN was convincingly demonstrated in patients with chronic myelogenous leukemia (CML) [138], as well as in patients with ET and PV [139,140,141].